Company | Ticker | Upcoming Earnings | Prepared |
Phillips 66 | PSX | Q2 2026 (~late July / early August 2026) | August 4, 2026 |
Key Takeaway: The setup into PSX’s Q2 2026 print is constructive-to-bullish — consensus is calling for a massive sequential and year-over-year earnings recovery driven by a historically strong refining margin environment, and peer prints from VLO and MPC confirm the macro tailwind was real; the biggest swing factor is how much of the Q1 mark-to-market hedge loss reverses and whether refining capture rate surprises to the upside again.
Heading into Q2 2026, Phillips 66 faces a consensus bar that is high in absolute terms but arguably still beatable given the exceptional refining macro backdrop confirmed by peers. Consensus is modeling adjusted EPS of ~$7.68 and Refining Adjusted EBITDA of ~$2.9 billion — a dramatic swing from Q1’s $0.49 EPS (which was itself a beat vs. expectations for a loss). Management’s tone on the Q1 call was actively bullish across refining, chemicals, and renewable fuels, with Q2 guidance calling for worldwide crude utilization in the low-to-mid 90s and turnaround expense of $120–$150 million — a lighter cost quarter than Q1. Estimate revisions have moved sharply higher since the Q1 print (Q2 EPS consensus up from $6.04 to $7.68, a +27% revision), tracking the strong macro signals from peers who reported first. The stock has already priced in significant improvement — PSX is up ~19% since the Q1 earnings date vs. XLE flat and SPY +8% — meaning the bar for a positive reaction is higher, but the wildcard is the magnitude of mark-to-market hedge reversal (management guided that a significant portion of Q1’s non-cash losses should reverse by year-end based on the forward curve) and whether commercial capture again surprises to the upside as it did in Q1.
Key Takeaway: Consensus is a high absolute bar — Q2 EPS of $7.68 implies a ~15x sequential jump from Q1 — but the refining macro environment confirmed by VLO and MPC suggests the bar is achievable; Refining Adjusted EBITDA is the bigger swing factor, given its sensitivity to crude differentials, capture rate, and the partial reversal of Q1 mark-to-market losses.
KPI | Last Quarter Actual (Q1 2026) | Prior Year Period (Q2 2025 Actual) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance (from Q1 call) | Consensus vs. Guidance |
Adj. EPS — Diluted Operating ($) | $0.49 | $2.38 | $7.68 | +223% YoY | No specific EPS guidance provided | N/A |
Refining Adj. EBITDA ($M) | $423M | $835M | $2,923M | +250% YoY | Crude utilization low-to-mid 90s; T/A expense $120–$150M | Above guidance range (macro-driven upside) |
Midstream Adj. EBITDA ($M) | $865M | $991M | $998M | +0.7% YoY | No specific guidance; organic growth trajectory intact | N/A |
Chemicals Adj. EBITDA ($M) | $85M | $20M | $389M | +1,845% YoY | Global O&P utilization low 80s (Middle East JV uncertainty) | Consensus well above prior-year; utilization headwind flagged |
Marketing, Specialties & Other Adj. EBITDA ($M) | -$121M | $693M | $492M | -29% YoY | No specific guidance | N/A |
Refinery Crude Utilization (%) | 100.8% | 104.3% | 100.1% | -4.2 ppts YoY | Low-to-mid 90s (worldwide crude utilization) | Consensus above guidance midpoint; strong operational track record |
Controllable Cost ex-T/A per Bbl — Refining ($) | $6.10/bbl | $4.73/bbl | $5.22/bbl | +10.4% YoY | Targeting $5.50/bbl by end-2027; Q1 showed meaningful YoY improvement | Consensus tracking toward target; improvement trajectory intact |
Total Refining Throughput (Mbpd) | 2,009 Mbpd | 1,921 Mbpd | 1,979 Mbpd | +3.0% YoY | Consistent with low-to-mid 90s utilization guidance | In line with guidance |
Source: Visible Alpha consensus and actuals data. All figures in USD millions unless noted. Q2 2026 consensus as of August 4, 2026.
KPI 1: Adj. EPS — Diluted Operating ($)
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $0.49 | -$0.45 | +209% | BEAT |
Q4 2025 | $2.47 | $2.17 | +14% | BEAT |
Q3 2025 | $2.52 | $2.15 | +17% | BEAT |
Q2 2025 | $2.38 | $1.68 | +42% | BEAT |
Q1 2025 | -$0.90 | -$0.72 | -25% | MISS |
Q4 2024 | -$0.15 | -$0.23 | +37% | BEAT |
Q3 2024 | $2.04 | $1.65 | +24% | BEAT |
Q2 2024 | $2.31 | $1.98 | +17% | BEAT |
Pattern: PSX has beaten adjusted EPS consensus in 7 of the last 8 quarters, with the sole miss in Q1 2025 driven by mark-to-market hedge losses — the same dynamic that depressed Q1 2026 reported results but was ultimately beaten; the consistent beat pattern reflects management’s conservative guidance posture and commercial execution upside.
KPI 2: Refining Adjusted EBITDA ($M)
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q1 2026 | $423M | -$70M | N/M (swing to profit) | BEAT |
Q4 2025 | $1,019M | $927M | +10% | BEAT |
Q3 2025 | $874M | $870M | +0.5% | BEAT |
Q2 2025 | $835M | $659M | +27% | BEAT |
Q1 2025 | -$481M | -$494M | +3% | BEAT |
Q4 2024 | -$324M | -$375M | +14% | BEAT |
Q3 2024 | $163M | $133M | +23% | BEAT |
Q2 2024 | $506M | $413M | +22% | BEAT |
Pattern: PSX has beaten Refining Adjusted EBITDA consensus in all 8 of the last 8 quarters, with an average surprise of ~+25% (excluding the Q1 2026 N/M swing); the consistent beat pattern reflects both conservative guidance and commercial capture upside from crude optimization and trading.
Source: Visible Alpha consensus and actuals data.
Key Takeaway: Guidance has not been formally revised since the Q1 2026 earnings call (April 29, 2026), but management’s tone has shifted to actively bullish across refining, chemicals, and renewable fuels — the Western Gateway Pipeline FID is now targeted for mid-to-late summer 2026, and the Zeus Gas Plant / third Coastal Bend Fractionator received FID in May 2026, extending the midstream growth runway.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 29) | Revised Guidance | Current Consensus | Note |
Q2 2026 Worldwide Crude Utilization | Low-to-mid 90s (%) | — | ~100.1% (consensus) | Unchanged; consensus above guidance midpoint, consistent with PSX’s track record of running above guidance |
Q2 2026 Turnaround Expense | $120M – $150M | — | N/A — not separately tracked in VA | Unchanged; lighter T/A quarter vs. Q1; favorable cost tailwind |
Q2 2026 Corporate & Other Costs | $430M – $450M | — | N/A — not separately tracked in VA | Unchanged |
Q2 2026 Chemicals O&P Utilization | Low 80s (%) | — | N/A — not separately tracked in VA | Unchanged; Middle East JV uncertainty flagged; CVX confirmed CPChem margins “buoyant” in Q2 |
Refining Controllable Cost Target | $5.50/bbl by end-2027 | — | $5.22/bbl (Q2 2026 consensus) | Unchanged; consensus tracking ahead of target; management described Q1 as “within striking range” of 2027 target when normalized for nat gas |
Midstream Adj. EBITDA Run Rate Target | $4.0B → $4.5B by end-2027 | — | $3.91B FY2026 consensus | Unchanged; Zeus Gas Plant + 3rd Coastal Bend Fractionator received FID May 2026, extending runway to 2028 |
Annual Debt Reduction Target | ~$1.5B/year in 2026 and 2027; target $17B total debt | — | N/A — not separately tracked in VA | Unchanged; management noted target could be reached ahead of schedule if cash flows exceed expectations |
Western Gateway Pipeline FID | Mid-to-late summer 2026 (2029 in-service) | — | N/A | Unchanged; JV arrangements with Kinder Morgan and shipper transportation agreements being finalized; FID imminent |
Key Takeaway: Estimates have moved sharply higher since the Q1 2026 print — Q2 2026 EPS consensus is up +27% and Refining EBITDA is up +30% from the post-Q1 baseline — tracking the strong refining macro signals from peers; the gap between current consensus and Q1 guidance is a potential cushion rather than a risk, given PSX’s consistent history of beating conservative guidance.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 5, 2026) | Current Consensus (Aug 4, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Diluted Operating (Q2 2026) | $6.04 | $7.68 | +27.2% | No specific guidance | No specific guidance | N/A | N/A |
Adj. EPS — Diluted Operating (FY 2026) | $16.97 | $21.71 | +27.9% | No specific guidance | No specific guidance | N/A | N/A |
Refining Adj. EBITDA (Q2 2026) | $2,243M | $2,923M | +30.3% | Crude util. low-to-mid 90s; T/A $120–$150M | Unchanged | No change | Consensus well above guidance range (macro-driven) |
Refining Adj. EBITDA (FY 2026) | $6,588M | $7,899M | +19.9% | No FY guidance provided | No FY guidance provided | N/A | N/A |
Midstream Adj. EBITDA (Q2 2026) | $999M | $998M | -0.1% | No specific guidance | Unchanged | No change | N/A |
Midstream Adj. EBITDA (FY 2026) | $3,925M | $3,909M | -0.4% | $4.0B–$4.5B run rate by end-2027 | Unchanged | No change | Tracking toward target |
Chemicals Adj. EBITDA (Q2 2026) | $357M | $389M | +9.0% | O&P utilization low 80s | Unchanged | No change | Consensus above guidance; CVX confirmed CPChem margins “buoyant” |
Source: Visible Alpha consensus and actuals data. Post-Q1 baseline as of May 5, 2026 (5 trading days after April 29, 2026 earnings). The sharp upward revision in EPS and Refining EBITDA since the Q1 print reflects the strong refining macro environment confirmed by VLO (Q2 refining operating income of $4.5B, up from $1.3B YoY) and MPC (Q2 R&M EBITDA/bbl of $24.84 with 112% capture rate) — both reporting before PSX. Midstream estimates are stable, reflecting the predictable, fee-based nature of that segment.
Key Takeaway: PSX has dramatically outperformed both its sector ETF (XLE) and the broader market since Q1 2026 earnings — up ~+19% vs. XLE -1% and SPY +8% — driven by a combination of estimate revisions (EPS consensus up ~+28% since the print) and multiple re-rating as the market gains confidence in the refining macro recovery and PSX’s transformation narrative; the stock’s outperformance raises the bar for a positive reaction on Q2 results.
PSX vs. XLE vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (April 29, 2026). Sector ETF: XLE (Energy Select Sector SPDR), appropriate for PSX’s downstream/integrated energy sub-sector.
Key Takeaway: VLO, MPC, XOM, and CVX all reported Q2 2026 results before PSX and collectively confirm an exceptionally strong refining macro environment — record margins, tight global product inventories, and constructive crude differentials — that directly benefits PSX’s refining, chemicals, and renewable fuels segments; the read-through is unambiguously positive for PSX’s Q2 print, with the key question being the magnitude of commercial capture and mark-to-market reversal.
Read-Through: Strongly positive for PSX refining and chemicals.
Read-Through: Strongly positive for PSX refining and crude differential outlook.
Read-Through: Positive for refining and chemicals; confirms structural tightness in global refining capacity.
Read-Through: Positive for PSX chemicals (CPChem) and refining margins.
Theme | Peer Signal | PSX Implication | Direction |
Refining Margins (Q2) | VLO: $4.4B adj. op. income; MPC: $24.84/bbl EBITDA, 112% capture; XOM: “very robust”; CVX: higher margins + record throughput | Confirms Q2 2026 was an exceptional refining quarter; PSX consensus of $2.9B Refining EBITDA is achievable | Positive |
WCS / Heavy Crude Differentials | MPC: WCS at WTI -$14/bbl; forward curve shows -$16/bbl in Q4; ran record Canadian heavy in Gulf Coast. VLO: bullish on heavy sour discounts going forward | WCS widening is PSX’s largest earnings sensitivity (~$140M per $1); forward curve tailwind supports Q3/Q4 outlook | Positive |
Chemicals Margins (CPChem) | CVX: CPChem margins “buoyant”; XOM: chemical margins +180% vs. Q1; both cite ethane advantage vs. constrained naphtha | PSX’s 50% CPChem stake should deliver strong Q2 chemicals EBITDA; consensus of $389M vs. $20M in Q2 2025 is well-supported | Positive |
Renewable Fuels / RINs | VLO: RD operating income $717M vs. -$79M YoY; D4 RINs expected above fat prices through 2026–27; RIN bank depleting by end-2026 | Positive for PSX’s Rodeo facility (running above nameplate; RINs >2x 2025 levels); renewable fuels segment positioned for material YoY FCF improvement | Positive |
Q3 2026 Outlook | MPC: margins “good but not at Q2 levels”; VLO: Q3 margins “stronger than Q2” on feedstock tailwinds; both expect constructive environment through year-end | Mixed signals on Q3 vs. Q2 magnitude, but overall constructive; PSX’s Q3 setup benefits from WCS widening and lighter turnaround schedule | Constructive |
Global Capacity / Supply Tightness | VLO: ~5M bpd offline; MPC: 9M bpd downtime (4M above norms); XOM: available capacity at COVID-era lows; Russian capacity progressively worsening | Structural tightness supports elevated refining margins through 2026–2027; PSX’s pipeline-connected crude sourcing provides insulation from Brent-priced crude volatility | Positive |
Key Takeaway: The most important development since Q1 earnings is the FID on Zeus Gas Plant and the third Coastal Bend Fractionator (May 2026), extending PSX’s midstream organic growth runway to 2028 and beyond the $4.5B EBITDA target — a structural positive that the market is beginning to price in; the Western Gateway Pipeline FID (targeted mid-to-late summer 2026) is the next major catalyst.